Literature DB >> 21113792

Density distribution of free fatty acid receptor 2 (FFA2)-expressing and GLP-1-producing enteroendocrine L cells in human and rat lower intestine, and increased cell numbers after ingestion of fructo-oligosaccharide.

Izumi Kaji1, Shin-Ichiro Karaki, Ryo Tanaka, Atsukazu Kuwahara.   

Abstract

Glucagon-like peptide 1 (GLP-1) is a multifunctional hormone in glucose metabolism and intestinal function released by enteroendocrine L-cells. The plasma concentration of GLP-1 is increased by indigestible carbohydrates and luminal infusion of short-chain fatty acids (SCFAs). However, the triggers and modulators of the GLP-1 release remain unclear. We hypothesized that SCFAs produced by bacterial fermentation are involved in enteroendocrine cell proliferation and hormone release through free fatty acid receptor 2 (FFA2, also known as FFAR2 or GPR43) in the large intestine. Fructo-oligosaccharide (Fructo-OS), fermentable indigestible carbohydrate, was used as a source of SCFAs. Rats were fed an indigestible-carbohydrate-free diet (control) or a 5% Fructo-OS-containing diet for 28 days. FFA2-, GLP-1-, and 5-hydroxytryptamine (5-HT)-positive enteroendocrine cells were quantified immunohistochemically in the colon, cecum, and terminal ileum. The same analysis was performed in surgical specimens from human lower intestine. The coexpression of FFA2 with GLP-1 was investigated both in rats and humans. Fructo-OS supplementation in rats increased the densities of FFA2-positive enteroendocrine cells in rat proximal colon, by over two-fold, relative to control, in parallel with GLP-1-containing L-cells. The segmental distributions of these cells in human were similar to rats fed the control diet. The FFA2-positive enteroendocrine cells were GLP-1-containing L-cells, but not 5-HT-containing EC cells, in both human and rat colon and terminal ileum. Fermentable indigestible carbohydrate increases the number of FFA2-positive L-cells in the proximal colon. FFA2 activation by SCFAs might be an important trigger for produce and release GLP-1 by enteroendocrine L-cells in the lower intestine.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21113792     DOI: 10.1007/s10735-010-9304-4

Source DB:  PubMed          Journal:  J Mol Histol        ISSN: 1567-2379            Impact factor:   2.611


  40 in total

1.  Selected indigestible oligosaccharides affect large bowel mass, cecal and fecal short-chain fatty acids, pH and microflora in rats.

Authors:  J M Campbell; G C Fahey; B W Wolf
Journal:  J Nutr       Date:  1997-01       Impact factor: 4.798

2.  Propionate modulates spontaneous contractions via enteric nerves and prostaglandin release in the rat distal colon.

Authors:  Retsu Mitsui; Shigeyuki Ono; Shin-ichiro Karaki; Atsukazu Kuwahara
Journal:  Jpn J Physiol       Date:  2005-12-10

3.  Clinical, microbiological, and immunological effects of fructo-oligosaccharide in patients with Crohn's disease.

Authors:  J O Lindsay; K Whelan; A J Stagg; P Gobin; H O Al-Hassi; N Rayment; M A Kamm; S C Knight; A Forbes
Journal:  Gut       Date:  2005-09-14       Impact factor: 23.059

4.  Short-chain fatty acid receptor, GPR43, is expressed by enteroendocrine cells and mucosal mast cells in rat intestine.

Authors:  Shin-ichiro Karaki; Retsu Mitsui; Hisayoshi Hayashi; Ikuo Kato; Hiroshi Sugiya; Toshihiko Iwanaga; John B Furness; Atsukazu Kuwahara
Journal:  Cell Tissue Res       Date:  2006-02-01       Impact factor: 5.249

5.  Glucagon-like peptide-1 inhibits gastric emptying via vagal afferent-mediated central mechanisms.

Authors:  N Imeryüz; B C Yeğen; A Bozkurt; T Coşkun; M L Villanueva-Peñacarrillo; N B Ulusoy
Journal:  Am J Physiol       Date:  1997-10

6.  GLP-1 slows solid gastric emptying and inhibits insulin, glucagon, and PYY release in humans.

Authors:  E Näslund; J Bogefors; S Skogar; P Grybäck; H Jacobsson; J J Holst; P M Hellström
Journal:  Am J Physiol       Date:  1999-09

Review 7.  Role of incretin hormones in the regulation of insulin secretion in diabetic and nondiabetic humans.

Authors:  Jens Juul Holst; Jesper Gromada
Journal:  Am J Physiol Endocrinol Metab       Date:  2004-08       Impact factor: 4.310

8.  Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.

Authors:  T Vilsbøll; T Krarup; J Sonne; S Madsbad; A Vølund; A G Juul; J J Holst
Journal:  J Clin Endocrinol Metab       Date:  2003-06       Impact factor: 5.958

9.  Inulin-type fructans modulate gastrointestinal peptides involved in appetite regulation (glucagon-like peptide-1 and ghrelin) in rats.

Authors:  Patrice D Cani; Cédric Dewever; Nathalie M Delzenne
Journal:  Br J Nutr       Date:  2004-09       Impact factor: 3.718

10.  Sympathetic pathways mediate GLP-1 actions in the gastrointestinal tract of the rat.

Authors:  M Giralt; P Vergara
Journal:  Regul Pept       Date:  1998-04-24
View more
  42 in total

Review 1.  Diet: friend or foe of enteroendocrine cells--how it interacts with enteroendocrine cells.

Authors:  Sofia Moran-Ramos; Armando R Tovar; Nimbe Torres
Journal:  Adv Nutr       Date:  2012-01-05       Impact factor: 8.701

2.  α-Synuclein in gut endocrine cells and its implications for Parkinson's disease.

Authors:  Rashmi Chandra; Annie Hiniker; Yien-Ming Kuo; Robert L Nussbaum; Rodger A Liddle
Journal:  JCI Insight       Date:  2017-06-15

Review 3.  Parkinson's disease from the gut.

Authors:  Rodger A Liddle
Journal:  Brain Res       Date:  2018-01-31       Impact factor: 3.252

Review 4.  Peripheral neural targets in obesity.

Authors:  Amanda J Page; Erin Symonds; Madusha Peiris; L Ashley Blackshaw; Richard L Young
Journal:  Br J Pharmacol       Date:  2012-07       Impact factor: 8.739

Review 5.  Pathobiology and potential therapeutic value of intestinal short-chain fatty acids in gut inflammation and obesity.

Authors:  Jessica Soldavini; Jonathan D Kaunitz
Journal:  Dig Dis Sci       Date:  2013-07-10       Impact factor: 3.199

6.  FFA2 activation combined with ulcerogenic COX inhibition induces duodenal mucosal injury via the 5-HT pathway in rats.

Authors:  Yasutada Akiba; Koji Maruta; Kazuyuki Narimatsu; Hyder Said; Izumi Kaji; Ayaka Kuri; Ken-Ichi Iwamoto; Atsukazu Kuwahara; Jonathan D Kaunitz
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-05-19       Impact factor: 4.052

7.  Short-chain fatty acid sensing in rat duodenum.

Authors:  Yasutada Akiba; Takuya Inoue; Izumi Kaji; Masaaki Higashiyama; Kazuyuki Narimatsu; Ken-ichi Iwamoto; Masahiko Watanabe; Paul H Guth; Eli Engel; Atsukazu Kuwahara; Jonathan D Kaunitz
Journal:  J Physiol       Date:  2015-02-01       Impact factor: 5.182

Review 8.  Gut microbiota and GLP-1.

Authors:  Amandine Everard; Patrice D Cani
Journal:  Rev Endocr Metab Disord       Date:  2014-09       Impact factor: 6.514

9.  The acetate switch of an intestinal pathogen disrupts host insulin signaling and lipid metabolism.

Authors:  Saiyu Hang; Alexandra E Purdy; William P Robins; Zhipeng Wang; Manabendra Mandal; Sarah Chang; John J Mekalanos; Paula I Watnick
Journal:  Cell Host Microbe       Date:  2014-11-12       Impact factor: 21.023

10.  Improvement in glucose tolerance and insulin sensitivity by probiotic strains of Indian gut origin in high-fat diet-fed C57BL/6J mice.

Authors:  Mahalingam Balakumar; Durai Prabhu; Chandrakumar Sathishkumar; Paramasivam Prabu; Namita Rokana; Ramesh Kumar; Srividhya Raghavan; Avinash Soundarajan; Sunita Grover; Virender Kumar Batish; Viswanathan Mohan; Muthuswamy Balasubramanyam
Journal:  Eur J Nutr       Date:  2016-10-18       Impact factor: 5.614

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.